Alligator Bioscience (Sweden) Performance
| ATORX-TO-9 | 0.07 0.01 28.79% |
On a scale of 0 to 100, Alligator Bioscience holds a performance score of 2. The firm shows a Beta (market volatility) of 2.79, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Alligator Bioscience will likely underperform. Please check Alligator Bioscience's treynor ratio, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether Alligator Bioscience's price patterns will revert.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Alligator Bioscience AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Alligator Bioscience unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Alligator |
Alligator Bioscience Relative Risk vs. Return Landscape
If you would invest 14.00 in Alligator Bioscience AB on August 25, 2024 and sell it today you would lose (7.38) from holding Alligator Bioscience AB or give up 52.71% of portfolio value over 90 days. Alligator Bioscience AB is generating 0.5441% of daily returns and assumes 20.9881% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Alligator on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Alligator Bioscience Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alligator Bioscience's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Alligator Bioscience AB, and traders can use it to determine the average amount a Alligator Bioscience's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0259
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATORX-TO-9 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 20.99 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.54 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Alligator Bioscience is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alligator Bioscience by adding it to a well-diversified portfolio.
Things to note about Alligator Bioscience performance evaluation
Checking the ongoing alerts about Alligator Bioscience for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Alligator Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Alligator Bioscience is way too risky over 90 days horizon | |
| Alligator Bioscience has some characteristics of a very speculative penny stock | |
| Alligator Bioscience appears to be risky and price may revert if volatility continues |
- Analyzing Alligator Bioscience's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Alligator Bioscience's stock is overvalued or undervalued compared to its peers.
- Examining Alligator Bioscience's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Alligator Bioscience's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Alligator Bioscience's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Alligator Bioscience's stock. These opinions can provide insight into Alligator Bioscience's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Alligator Stock Analysis
When running Alligator Bioscience's price analysis, check to measure Alligator Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alligator Bioscience is operating at the current time. Most of Alligator Bioscience's value examination focuses on studying past and present price action to predict the probability of Alligator Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alligator Bioscience's price. Additionally, you may evaluate how the addition of Alligator Bioscience to your portfolios can decrease your overall portfolio volatility.